Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Secondary to Age-related Macular Degeneration (AMD)”

240 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 240 results

Testing effectiveness (Phase 2)WithdrawnNCT02122159
What this trial is testing

Research With Retinal Cells Derived From Stem Cells for Myopic Macular Degeneration

Who this might be right for
Myopic Macular Degeneration
University of California, Los Angeles
Not applicableEnded earlyNCT03894020
What this trial is testing

GTSCOPE - To Evaluate the Natural Progression of Dry Age-related Macular Degeneration (AMD)

Who this might be right for
Dry Age-related Macular DegenerationMacular DegenerationRetinal Disease+3 more
Gyroscope Therapeutics Limited 83
Testing effectiveness (Phase 2)Study completedNCT00492284
What this trial is testing

Reduced Fluence Visudyne-Anti-VEGF-Dexamethasone In Combination for AMD Lesions (RADICAL)

Who this might be right for
Choroidal NeovascularizationMacular Degeneration
QLT Inc. 162
Post-approval studies (Phase 4)Study completedNCT00682240
What this trial is testing

Morphological and Functional Retinal Changes Following Retinal Photocoagulation

Who this might be right for
Proliferative Diabetic RetinopathyMacular Edema
Medical University of Vienna 64
Large-scale testing (Phase 3)Study completedNCT07214740
What this trial is testing

Study to Evaluate a Pegcetacoplan (Syfovre®) Prefilled Syringe

Who this might be right for
Geographic Atrophy Secondary to Age-related Macular Degeneration
Apellis Pharmaceuticals, Inc. 44
Early research (Phase 1)Study completedNCT03295877
What this trial is testing

Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)

Who this might be right for
Geographic Atrophy
Genentech, Inc. 28
Testing effectiveness (Phase 2)Study completedNCT03033108
What this trial is testing

Pharmacodynamic Study of Emixustat Hydrochloride in Subjects With Macular Atrophy Secondary to Stargardt Disease

Who this might be right for
Stargardt DiseaseMacular Atrophy
Kubota Vision Inc. 23
Testing effectiveness (Phase 2)Looking for participantsNCT06659549
What this trial is testing

Efficacy and Safety Study of GAL-101, 2% Ophthalmic Solution in Non-foveal Geographic Atrophy Secondary to Non-neovascular AMD

Who this might be right for
Geographic Atrophy of the Macula
Galimedix Therapeutics Inc 110
Testing effectiveness (Phase 2)Study completedNCT00284089
What this trial is testing

Safety and Efficacy of Ranibizumab in Japanese Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration

Who this might be right for
Subfoveal Choroidal Neovascularization(CNV) Secondary to Age-related Macular Degeneration (AMD)
Novartis 88
Testing effectiveness (Phase 2)Looking for participantsNCT07160179
What this trial is testing

Study to Assess the Adverse Events and How Intravitreal ABBV-6628 Moves Through the Body of Adult Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Who this might be right for
Geographic AtrophyAge-Related Macular Degeneration
AbbVie 66
Not applicableStudy completedNCT05003258
What this trial is testing

Functional and Anatomical Outcomes of Dexamethasone Intra-vitreal Implant in Patients with Resistant Macular Edema Secondary to Retinal Vein Occlusion After Intravitreal Anti-VEGF Injection

Who this might be right for
Macular EdemaRetinal Vein Occlusion
Assiut University 25
Not applicableLooking for participantsNCT07144137
What this trial is testing

A Non-Interventional Study Observing Short-Term Progression in Geographic Atrophy (GA)

Who this might be right for
Geographic Atrophy Secondary to Age-related Macular Degeneration
Complement Therapeutics 75
Testing effectiveness (Phase 2)Study completedNCT02614937
What this trial is testing

Study of Squalamine Lactate for the Treatment of Macular Edema Related to Retinal Vein Occlusion

Who this might be right for
Retinal Vein OcclusionMacular Edema
Ohr Pharmaceutical Inc. 20
Not applicableStudy completedNCT01219205
What this trial is testing

Major and Macular Branched Retinal Venous Occlusion

Who this might be right for
Macular Edema
Hallym University Medical Center 46
Large-scale testing (Phase 3)Study completedNCT04592419
What this trial is testing

Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Patients With Macular Edema Due to Retinal Vein Occlusion (RVO)

Who this might be right for
Macular EdemaRetinal Vein Occlusion
Kodiak Sciences Inc 568
Large-scale testing (Phase 3)Study completedNCT00470678
What this trial is testing

EXTEND III - Efficacy and Safety of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration (AMD)

Who this might be right for
Choroidal NeovascularizationAge-Related Macular Degeneration
Novartis 95
Not applicableActive Not RecruitingNCT06161584
What this trial is testing

A Prospective, Multicenter, Open-Label, Observational Phase 4 Study to Evaluate Real-World Safety, Tolerability, and Treatment Patterns of Pegcetacoplan (Syfovre) in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Who this might be right for
Geographic Atrophy
Apellis Pharmaceuticals, Inc. 300
Early research (Phase 1)Study completedNCT06006585
What this trial is testing

Test How Well Different Doses of BI 771716 Are Tolerated by People With an Advanced Form of Age-related Macular Degeneration (AMD) Called Geographic Atrophy

Who this might be right for
Geographic Atrophy
Boehringer Ingelheim 20
Post-approval studies (Phase 4)Active Not RecruitingNCT06970665
What this trial is testing

A Study About the Safety of ASP3021 Eye Injections and if They Help People in Japan With Vision Loss From Age-related Macular Degeneration

Who this might be right for
Geographic AtrophyAge-Related Macular Degeneration
Astellas Pharma Inc 17
Early research (Phase 1)Study completedNCT04615325
What this trial is testing

A Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7303359 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration

Who this might be right for
Geographic Atrophy
Hoffmann-La Roche 37
Next Page